- Home
- Welcome to Pharma Focus Asia
News
Archives - 2010
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LifeSpan BioSciences Establishes Global Antibody Distribution Network with Exclusive Partnerships
Seattle
Jul 13, 2010
Exclusive Partnerships Enhance Quality Customer
Support to Research Community
LifeSpan BioSciences, Inc. (LSBio), a leading provider of antibodies
to researchers worldwide, today announced exclusive distribution
agreements with select strategic partners making the full LSBio catalog
of 75,000 antibodies, including 3,600 IHC-validated, IHC-plus™
antibodies, available around the globe. LSBio expects to improve
international customer support by providing researchers worldwide with
local access to the Company’s vast catalog of high quality, well
characterized and diverse reagents and antibodies.
LSBio
inked exclusive distribution partnerships with companies who have
built solid reputations through significant experience in the biology
space. Exclusive distribution relationships include:
- Asia Bioscience Co Ltd for Taiwan
- Biocom Biotech for South Africa
- Bio-Connect BV for The Netherlands, Belgium
and Luxembourg
- Biozol Diagnostica Vertrieb GmbH for Germany
- CliniSciences s.a.s. for France
- Dong-in Biotech Co., Ltd for Republic of Korea
- IB Scientific for India
- LabForce AG for Switzerland
- Precision Technologies Pte Ltd for Singapore
- Sapphire Bioscience Pty. Ltd. for Australia
and New Zealand
- Source Biosciences for the United Kingdom and
Ireland
LSBio also sells their catalog of antibodies through
the LSBio website and globally via non-exclusive distributors and the
Antibodies-Online platform.
“Partnering with a leading-edge
IHC-validated reagent antibodies supplier enables us to provide highly
characterised, quality antibodies to our customers, which is critical to
the growth of our products business,” said Nick Ash, CEO at Source
BioScience. “This agreement will also enable us to supply additional
antibodies as LSBio continue the rapid expansion of their antibody
portfolio.”
“Our 15-year history in delivering IHC services and
validating antibodies for use in IHC makes LSBio exceptionally qualified
to meet the rising worldwide need for high-quality, IHC-validated
antibodies,” said LSBio CEO, Joe Brown, Ph.D. “By carefully
selecting premier distributors who share that experience and understand
the unique needs of the research community, we are able to provide one
of the best customer support systems in the world for antibody
reagents.”
LSBio has grown its antibody business exponentially
over the past three years, and researchers in more than 50 countries
across Africa, Asia, Europe, North America, and South America now rely
on LSBio for their antibodies.
About LifeSpan
LSBio
is the industry leader in providing immunohistochemistry (IHC) services
and IHC-validated reagent antibodies to researchers in the
pharmaceutical and biotech industries as well as in academia and other
research organizations worldwide. Founded in 1995, LSBio has built a
catalog of more than 75,000 reagent antibodies, including more than
3,600 IHC-plus™ antibodies. LSBio sells reagent antibodies from its
online catalog as well as through an expanding network of international
distributors.
Source: LifeSpan
© 2010 Ochre Media. All rights reserved.